SP 484 (see companion bill LD 1406) – MaineStatus: Enacted
Year Introduced: 2018
Year Enacted: 2018
AN ACT TO PROMOTE PRESCRIPTION DRUG PRICE TRANSPARENCY: requires the Attorney General to compile a list of certain drugs and list the drugs’ percentage of wholesale acquisition cost increase, if any, and make the list available to the public on a publicly accessible website. Drug manufactures would be required to provide justification of the increase of cost as well.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.